Alvotech (ALVO) Liabilities and Shareholders Equity (2020 - 2026)
Alvotech's (ALVO) quarterly Liabilities and Shareholders Equity came in at $1.6 billion in Q2 2026, up 13.98% on a YoY basis from $1.4 billion in Q2 2025, and up 11.7% quarter-over-quarter from $1.4 billion in Q1 2026.
Powered by 
Analysis
Alvotech (ALVO) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 13.98% year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2026 stood at $5.9 billion (up 15.95% YoY), and the FY2025 full-year result was $1.5 billion, up 21.75% from the prior year.
- Liabilities and Shareholders Equity improved to $1.6 billion in Q2 2026 per ALVO's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $1.6 billion in Q2 2026 and bottomed at $774.5 million in Q2 2022.
- Historically, Liabilities and Shareholders Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity surged 38.54% in 2022, then grew 13.98% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $828.4 million in 2022, then grew by 14.68% to $950.1 million in 2023, then gained by 28.56% to $1.2 billion in 2024, then gained by 21.75% to $1.5 billion in 2025, then increased by 6.75% to $1.6 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.6 billion, $1.4 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 39.86 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 35.04 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 6.08 Bn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 3.78 Bn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 24.79 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 1.49 Bn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 1.59 Bn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 1.74 Bn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 75.75 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | 6.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 950.09 Mn |
| Jun 30, 2023 | 910.66 Mn |
| Dec 31, 2022 | 828.44 Mn |
| Jun 30, 2022 | 774.50 Mn |
| Dec 31, 2021 | 597.98 Mn |
| Dec 31, 2020 | 474.42 Mn |
API Access
Alvotech Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ALVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ALVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ALVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();